Click for best price
Biological Drugs Market Size, Share 2022
The international biological drugs market is envisaged to grow at a handsome rate in the next few years. However, it could face challenges in the form of various product parameters, strict regulatory pathways and manufacturing processes, and longer product approvals, although biological drugs have historically shown better approval rates than conventional ones. Additionally, small players could find it difficult to enter the market because of the requirement of high capital expenditure.
This report contains market size and forecasts of Biological Drugs in global, including the following market information:
Global top five Biological Drugs companies in 2021 (%)
The global Biological Drugs market was valued at 291940 million in 2021 and is projected to reach US$ 495400 million by 2028, at a CAGR of 7.8% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Therapeutic Protein Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Biological Drugs include Bristol-Myers Squibb, Eli Lilly, Takeda, Pfizer, Amgen, F. Hoffmann-La Roche, Johnson & Johnson, Merck and Abbott Laboratories, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Biological Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Biological Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, by Type, 2021 (%)
- Therapeutic Protein
- Monoclonal Antibody
- Vaccine
- Others
Global Biological Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Biological Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Biological Drugs Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Biological Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
- Key companies Biological Drugs revenues share in global market, 2021 (%)
- Key companies Biological Drugs sales in global market, 2017-2022 (Estimated), (K MT)
- Key companies Biological Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bristol-Myers Squibb
- Eli Lilly
- Takeda
- Pfizer
- Amgen
- F. Hoffmann-La Roche
- Johnson & Johnson
- Merck
- Abbott Laboratories
- Baxter
- Novartis
- Biogen
- GlaxoSmithKline
| Report Attributes |
Report Details |
| Report Title |
Biological Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
72 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Biological Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biological Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biological Drugs Overall Market Size
2.1 Global Biological Drugs Market Size: 2021 VS 2028
2.2 Global Biological Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Biological Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top Biological Drugs Players in Global Market
3.2 Top Global Biological Drugs Companies Ranked by Revenue
3.3 Global Biological Drugs Revenue by Companies
3.4 Global Biological Drugs Sales by Companies
3.5 Global Biological Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Biological Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Biological Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Biological Drugs Players in Global Market
3.8.1 List of Global Tier 1 Biological Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Biological Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Biological Drugs Market Size Markets, 2021 & 2028
4.1.2 Therapeutic Protein
4.1.3 Monoclonal Antibody
4.1.4 Vaccine
4.1.5 Others
4.2 By Type - Global Biological Drugs Revenue & Forecasts
4.2.1 By Type - Global Biological Drugs Revenue, 2017-2022
4.2.2 By Type - Global Biological Drugs Revenue, 2023-2028
4.2.3 By Type - Global Biological Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global Biological Drugs Sales & Forecasts
4.3.1 By Type - Global Biological Drugs Sales, 2017-2022
4.3.2 By Type - Global Biological Drugs Sales, 2023-2028
4.3.3 By Type - Global Biological Drugs Sales Market Share, 2017-2028
4.4 By Type - Global Biological Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Biological Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Others
5.2 By Application - Global Biological Drugs Revenue & Forecasts
5.2.1 By Application - Global Biological Drugs Revenue, 2017-2022
5.2.2 By Application - Global Biological Drugs Revenue, 2023-2028
5.2.3 By Application - Global Biological Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global Biological Drugs Sales & Forecasts
5.3.1 By Application - Global Biological Drugs Sales, 2017-2022
5.3.2 By Application - Global Biological Drugs Sales, 2023-2028
5.3.3 By Application - Global Biological Drugs Sales Market Share, 2017-2028
5.4 By Application - Global Biological Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Biological Drugs Market Size, 2021 & 2028
6.2 By Region - Global Biological Drugs Revenue & Forecasts
6.2.1 By Region - Global Biological Drugs Revenue, 2017-2022
6.2.2 By Region - Global Biological Drugs Revenue, 2023-2028
6.2.3 By Region - Global Biological Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global Biological Drugs Sales & Forecasts
6.3.1 By Region - Global Biological Drugs Sales, 2017-2022
6.3.2 By Region - Global Biological Drugs Sales, 2023-2028
6.3.3 By Region - Global Biological Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Biological Drugs Revenue, 2017-2028
6.4.2 By Country - North America Biological Drugs Sales, 2017-2028
6.4.3 US Biological Drugs Market Size, 2017-2028
6.4.4 Canada Biological Drugs Market Size, 2017-2028
6.4.5 Mexico Biological Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Biological Drugs Revenue, 2017-2028
6.5.2 By Country - Europe Biological Drugs Sales, 2017-2028
6.5.3 Germany Biological Drugs Market Size, 2017-2028
6.5.4 France Biological Drugs Market Size, 2017-2028
6.5.5 U.K. Biological Drugs Market Size, 2017-2028
6.5.6 Italy Biological Drugs Market Size, 2017-2028
6.5.7 Russia Biological Drugs Market Size, 2017-2028
6.5.8 Nordic Countries Biological Drugs Market Size, 2017-2028
6.5.9 Benelux Biological Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Biological Drugs Revenue, 2017-2028
6.6.2 By Region - Asia Biological Drugs Sales, 2017-2028
6.6.3 China Biological Drugs Market Size, 2017-2028
6.6.4 Japan Biological Drugs Market Size, 2017-2028
6.6.5 South Korea Biological Drugs Market Size, 2017-2028
6.6.6 Southeast Asia Biological Drugs Market Size, 2017-2028
6.6.7 India Biological Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Biological Drugs Revenue, 2017-2028
6.7.2 By Country - South America Biological Drugs Sales, 2017-2028
6.7.3 Brazil Biological Drugs Market Size, 2017-2028
6.7.4 Argentina Biological Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Biological Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Biological Drugs Sales, 2017-2028
6.8.3 Turkey Biological Drugs Market Size, 2017-2028
6.8.4 Israel Biological Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia Biological Drugs Market Size, 2017-2028
6.8.6 UAE Biological Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Corporate Summary
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Biological Drugs Major Product Offerings
7.1.4 Bristol-Myers Squibb Biological Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Bristol-Myers Squibb Key News
7.2 Eli Lilly
7.2.1 Eli Lilly Corporate Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Biological Drugs Major Product Offerings
7.2.4 Eli Lilly Biological Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Eli Lilly Key News
7.3 Takeda
7.3.1 Takeda Corporate Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Biological Drugs Major Product Offerings
7.3.4 Takeda Biological Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Takeda Key News
7.4 Pfizer
7.4.1 Pfizer Corporate Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Biological Drugs Major Product Offerings
7.4.4 Pfizer Biological Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Pfizer Key News
7.5 Amgen
7.5.1 Amgen Corporate Summary
7.5.2 Amgen Business Overview
7.5.3 Amgen Biological Drugs Major Product Offerings
7.5.4 Amgen Biological Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Amgen Key News
7.6 F. Hoffmann-La Roche
7.6.1 F. Hoffmann-La Roche Corporate Summary
7.6.2 F. Hoffmann-La Roche Business Overview
7.6.3 F. Hoffmann-La Roche Biological Drugs Major Product Offerings
7.6.4 F. Hoffmann-La Roche Biological Drugs Sales and Revenue in Global (2017-2022)
7.6.5 F. Hoffmann-La Roche Key News
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Corporate Summary
7.7.2 Johnson & Johnson Business Overview
7.7.3 Johnson & Johnson Biological Drugs Major Product Offerings
7.7.4 Johnson & Johnson Biological Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Johnson & Johnson Key News
7.8 Merck
7.8.1 Merck Corporate Summary
7.8.2 Merck Business Overview
7.8.3 Merck Biological Drugs Major Product Offerings
7.8.4 Merck Biological Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Merck Key News
7.9 Abbott Laboratories
7.9.1 Abbott Laboratories Corporate Summary
7.9.2 Abbott Laboratories Business Overview
7.9.3 Abbott Laboratories Biological Drugs Major Product Offerings
7.9.4 Abbott Laboratories Biological Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Abbott Laboratories Key News
7.10 Baxter
7.10.1 Baxter Corporate Summary
7.10.2 Baxter Business Overview
7.10.3 Baxter Biological Drugs Major Product Offerings
7.10.4 Baxter Biological Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Baxter Key News
7.11 Novartis
7.11.1 Novartis Corporate Summary
7.11.2 Novartis Biological Drugs Business Overview
7.11.3 Novartis Biological Drugs Major Product Offerings
7.11.4 Novartis Biological Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Novartis Key News
7.12 Biogen
7.12.1 Biogen Corporate Summary
7.12.2 Biogen Biological Drugs Business Overview
7.12.3 Biogen Biological Drugs Major Product Offerings
7.12.4 Biogen Biological Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Biogen Key News
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Corporate Summary
7.13.2 GlaxoSmithKline Biological Drugs Business Overview
7.13.3 GlaxoSmithKline Biological Drugs Major Product Offerings
7.13.4 GlaxoSmithKline Biological Drugs Sales and Revenue in Global (2017-2022)
7.13.5 GlaxoSmithKline Key News
8 Global Biological Drugs Production Capacity, Analysis
8.1 Global Biological Drugs Production Capacity, 2017-2028
8.2 Biological Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Biological Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Biological Drugs Supply Chain Analysis
10.1 Biological Drugs Industry Value Chain
10.2 Biological Drugs Upstream Market
10.3 Biological Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Biological Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Biological Drugs in Global Market
Table 2. Top Biological Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Biological Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Biological Drugs Revenue Share by Companies, 2017-2022
Table 5. Global Biological Drugs Sales by Companies, (K MT), 2017-2022
Table 6. Global Biological Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Biological Drugs Price (2017-2022) & (USD/MT)
Table 8. Global Manufacturers Biological Drugs Product Type
Table 9. List of Global Tier 1 Biological Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Biological Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Biological Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Biological Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Biological Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Biological Drugs Sales (K MT), 2017-2022
Table 15. By Type - Global Biological Drugs Sales (K MT), 2023-2028
Table 16. By Application ? Global Biological Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Biological Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Biological Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Biological Drugs Sales (K MT), 2017-2022
Table 20. By Application - Global Biological Drugs Sales (K MT), 2023-2028
Table 21. By Region ? Global Biological Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Biological Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Biological Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Biological Drugs Sales (K MT), 2017-2022
Table 25. By Region - Global Biological Drugs Sales (K MT), 2023-2028
Table 26. By Country - North America Biological Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Biological Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Biological Drugs Sales, (K MT), 2017-2022
Table 29. By Country - North America Biological Drugs Sales, (K MT), 2023-2028
Table 30. By Country - Europe Biological Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Biological Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Biological Drugs Sales, (K MT), 2017-2022
Table 33. By Country - Europe Biological Drugs Sales, (K MT), 2023-2028
Table 34. By Region - Asia Biological Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Biological Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Biological Drugs Sales, (K MT), 2017-2022
Table 37. By Region - Asia Biological Drugs Sales, (K MT), 2023-2028
Table 38. By Country - South America Biological Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Biological Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Biological Drugs Sales, (K MT), 2017-2022
Table 41. By Country - South America Biological Drugs Sales, (K MT), 2023-2028
Table 42. By Country - Middle East & Africa Biological Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Biological Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Biological Drugs Sales, (K MT), 2017-2022
Table 45. By Country - Middle East & Africa Biological Drugs Sales, (K MT), 2023-2028
Table 46. Bristol-Myers Squibb Corporate Summary
Table 47. Bristol-Myers Squibb Biological Drugs Product Offerings
Table 48. Bristol-Myers Squibb Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 49. Eli Lilly Corporate Summary
Table 50. Eli Lilly Biological Drugs Product Offerings
Table 51. Eli Lilly Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 52. Takeda Corporate Summary
Table 53. Takeda Biological Drugs Product Offerings
Table 54. Takeda Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 55. Pfizer Corporate Summary
Table 56. Pfizer Biological Drugs Product Offerings
Table 57. Pfizer Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 58. Amgen Corporate Summary
Table 59. Amgen Biological Drugs Product Offerings
Table 60. Amgen Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 61. F. Hoffmann-La Roche Corporate Summary
Table 62. F. Hoffmann-La Roche Biological Drugs Product Offerings
Table 63. F. Hoffmann-La Roche Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 64. Johnson & Johnson Corporate Summary
Table 65. Johnson & Johnson Biological Drugs Product Offerings
Table 66. Johnson & Johnson Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 67. Merck Corporate Summary
Table 68. Merck Biological Drugs Product Offerings
Table 69. Merck Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 70. Abbott Laboratories Corporate Summary
Table 71. Abbott Laboratories Biological Drugs Product Offerings
Table 72. Abbott Laboratories Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 73. Baxter Corporate Summary
Table 74. Baxter Biological Drugs Product Offerings
Table 75. Baxter Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 76. Novartis Corporate Summary
Table 77. Novartis Biological Drugs Product Offerings
Table 78. Novartis Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 79. Biogen Corporate Summary
Table 80. Biogen Biological Drugs Product Offerings
Table 81. Biogen Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 82. GlaxoSmithKline Corporate Summary
Table 83. GlaxoSmithKline Biological Drugs Product Offerings
Table 84. GlaxoSmithKline Biological Drugs Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2017-2022)
Table 85. Biological Drugs Production Capacity (K MT) of Key Manufacturers in Global Market, 2020-2022 (K MT)
Table 86. Global Biological Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 87. Global Biological Drugs Production by Region, 2017-2022 (K MT)
Table 88. Global Biological Drugs Production by Region, 2023-2028 (K MT)
Table 89. Biological Drugs Market Opportunities & Trends in Global Market
Table 90. Biological Drugs Market Drivers in Global Market
Table 91. Biological Drugs Market Restraints in Global Market
Table 92. Biological Drugs Raw Materials
Table 93. Biological Drugs Raw Materials Suppliers in Global Market
Table 94. Typical Biological Drugs Downstream
Table 95. Biological Drugs Downstream Clients in Global Market
Table 96. Biological Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Biological Drugs Segment by Type
Figure 2. Biological Drugs Segment by Application
Figure 3. Global Biological Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Biological Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Biological Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. Biological Drugs Sales in Global Market: 2017-2028 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Biological Drugs Revenue in 2021
Figure 9. By Type - Global Biological Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global Biological Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global Biological Drugs Price (USD/MT), 2017-2028
Figure 12. By Application - Global Biological Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global Biological Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global Biological Drugs Price (USD/MT), 2017-2028
Figure 15. By Region - Global Biological Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global Biological Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America Biological Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America Biological Drugs Sales Market Share, 2017-2028
Figure 19. US Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Biological Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Biological Drugs Sales Market Share, 2017-2028
Figure 24. Germany Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Biological Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Biological Drugs Sales Market Share, 2017-2028
Figure 33. China Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Biological Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America Biological Drugs Sales Market Share, 2017-2028
Figure 40. Brazil Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Biological Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Biological Drugs Sales Market Share, 2017-2028
Figure 44. Turkey Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Biological Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global Biological Drugs Production Capacity (K MT), 2017-2028
Figure 49. The Percentage of Production Biological Drugs by Region, 2021 VS 2028
Figure 50. Biological Drugs Industry Value Chain
Figure 51. Marketing Channels
